Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 10 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACT-064992 | - | - | - | - | 5件: 51 51, 85, 86, 88, 210 💬
| ||||||||||
| 2 | ACT-064992 (macitentan) | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬2. ACT-064992 (macitentan)
| 2件: EDNRA EDNRA,EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | 1件: 85 85 💬2. ACT-064992 (macitentan)
| ||||||||||
| 3 | ACT-064992 / JNJ-67896062 | - | - | - | - | 1件: 86 86 💬3. ACT-064992 / JNJ-67896062
| ||||||||||
| 4 | ACT-064992/ JNJ-67896062 | - | - | - | - | 1件: 86 86 💬4. ACT-064992/ JNJ-67896062
| ||||||||||
| 5 | ACT-064992D | - | - | - | - | 1件: 86 86 💬5. ACT-064992D
| ||||||||||
| 6 | CJNJ-68150420-ZZZ-G001 (ACT-064992D) | - | - | - | - | 1件: 86 86 💬6. CJNJ-68150420-ZZZ-G001 (ACT-064992D)
| ||||||||||
| 7 | CJNJ-68150420-ZZZ-G001(ACT-064992D) | - | - | - | - | 1件: 86 86 💬7. CJNJ-68150420-ZZZ-G001(ACT-064992D)
| ||||||||||
| 8 | JNJ-67896062 / ACT-064992 | - | - | - | - | 2件: 86 86, 88 💬
| ||||||||||
| 9 | JNJ-67896062/ ACT-064992 | - | - | - | - | 2件: 86 86, 88 💬
| ||||||||||
| 10 | Macitentan (ACT-064992) | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬10. Macitentan (ACT-064992)
| 2件: EDNRA EDNRA,EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | 1件: 86 86 💬10. Macitentan (ACT-064992)
|